Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin in Refractory Traumatic Hemorrhagic Shock (VITRIS)
NCT00379522Phase 3Completed
- Start
- Jul 2010
- Primary completion
- Oct 2014
- Modality
- Peptides
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of vasopressin in hemorrhagic shock. Started Jul 2010; status: completed.
02
Drugs
vasopressin
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on NCT00379522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379522.